top of page
Haaruitval bij vrouwen, dunner wordend haar en kaalheid.

Haaruitval bij vrouwen

Wat is er te doen aan haaruitval bij vrouwen? 

Onze ervaren dermatologen helpen jou met een professionele beoordeling en door de beste medische oplossing te geven voor jouw specifieke situatie. 

Na het veertigste levensjaar ervaart maar liefst 40% van de vrouwen dat hun haar dunner wordt. Dit kan emotioneel belastend zijn, omdat je haar een belangrijk onderdeel is van je identiteit.
 

Verschillende oorzaken kunnen leiden tot overmatig haaruitval bij vrouwen.
Extreme stress-situaties zoals een bevalling, ziekte of hormonale schommelingen kunnen jouw lichaam ertoe brengen om tijdelijk veel haar te verliezen. Ook speelt erfelijkheid een rol bij dunner wordend haar.
 

Om de oorzaak van jouw haaruitval te achterhalen en de juiste behandelopties te bespreken, is het belangrijk om een gespecialiseerde dermatoloog te raadplegen.
Een accurate diagnose is essentieel voor het kiezen van de juiste behandeling en het voorspellen van het behandelresultaat. Je kunt een afspraak maken voor een persoonlijk consult met een dermatoloog om jouw haarprobleem te bespreken.
 

Bij onze haarkliniek bieden we verschillende behandelingsopties, afhankelijk van de oorzaak van jouw haaruitval. Of het nu gaat om alopecia androgenetica, telogeen effluvium, cicatriciële alopecie of alopecia areata, we kunnen je voorzien van deskundig advies en op maat gemaakte behandelplannen om jouw haargezondheid te verbeteren.
 

Onthoud dat niet elke behandeling geschikt is voor iedereen, en het raadplegen van een dermatoloog zal je helpen om de beste oplossing te vinden die past bij jouw specifieke situatie. We staan voor je klaar om je te ondersteunen bij het aanpakken van jouw haarproblemen en het herstellen van een gezonde haargroei.

De meest voorkomende haarproblemen bij vrouwen zijn:

Erfelijke aanleg voor haaruitval
Alopecia androgenetica

Wat in de volksmond gewone of klassieke kaalheid wordt genoemd, heet in de geneeskunde alopecia androgenetica.  Alopecia androgenetica komt zowel bij mannen als bij vrouwen voor. Haarverlies of dunner wordend haar bij vrouwen door alopecia androgenetica is een proces dat –naast erfelijkheid- wordt beïnvloed door ras, geslacht, leeftijd en een combinatie van genetische en hormonale factoren, waarbij dihydrotestosteron (DHT) een rol speelt.  

Bij alopecia androgenetica worden de haarzakjes geleidelijk kleiner en produceren ze dunner en korter haar, wat resulteert in een verlies van haardichtheid en volume. Het begint meestal op specifieke plekken op de hoofdhuid, zoals de kruin bij mannen en de middenscheiding bij vrouwen, en kan zich geleidelijk uitbreiden naar andere delen van de hoofdhuid.

Vrouw met alopecia androgenetica
  • What causes androgenetic alopecia?
    Each hair follicle can produce a hair approximately 20 times per lifetime, after which it dies. Because each hair remains in the hair follicle for three to five years, a person would only experience baldness after 60 to 90 years. Baldness at a young age with a hereditary cause is caused by the degree of sensitivity of certain hair follicles to the hormone dihydrotestosterone (DHT). This DHT is formed from the hormone testosterone under the influence of an enzyme (5-alpha-reductase, types I and II). The DHT binds to the androgen receptor (a 'biological magnet') of the hair follicle, which therefore has less blood flow. The growth phase of the hair is therefore shortened from three to five years to just a few months. The affected hairs become finer and shorter with each hair cycle and the hair follicle eventually dies at an accelerated rate. If this process occurs in many hair follicles, the hair becomes thinner. The number of androgen receptors a person has is genetically determined and that explains why some people go bald and others do not.
  • What treatment options are there for androgenetic alopecia?
    There are quite a few products and treatments that claim to have an effect on stopping hair loss due to androgenetic alopecia (hereditary baldness). Every two months a new shampoo, lotion or nutritional supplement comes onto the market with claimed effectiveness. Unfortunately, these claims are usually empty promises and the effect cannot be scientifically proven. However, there are also plenty of options whose effectiveness has been proven in scientific studies. Below is an overview of the treatment options used at Intermedica. The effectiveness of the products can be expressed as a percentage of full effectiveness, where hair loss is completely normalized. The effectiveness of the products for which scientific evidence is available is as follows (estimates): Minoxidil lotion: 25% Diane pill, Yasmin pill or Yaz pill: 25% Trix Basic Alpha + Trix Basic Beta: 25% Aminexil: 20% Androcur: 20% Other nutritional supplements: 0-10% Shampoos with Aminexil: 5% Other shampoos and lotions: 0-2% The effectiveness of the various products should not be added together. However, the effectiveness of one product can be improved slightly if another product is used. In addition, treatments are offered for which there is also only weak evidence that they inhibit the process of hair loss due to androgenetic alopecia. Examples of such treatments are light and laser treatments and the injection of vitamins and minerals into the scalp (PRP, mesotherapy). These are not carried out at Intermedica.
  • What about finasteride and dutasteride for women?
    The drugs finasteride and dutasteride have been prescribed for a long time and with good clinical results to women with hair loss due to androgenetic alopecia by the dermatologists of the Intermedica Clinic. These medicines are prescribed off-label. Off-label use of medicines means that they are prescribed for a purpose or in a different way than that for which they were approved. This is done based on a doctor's professional assessment. This is legally permitted. Finasteride and dutasteride were originally approved and prescribed for the treatment of prostate problems, but in low doses they also appear to be effective in preventing hair loss due to androgenetic alopecia, a so-called positive side effect. Finasteride and dutasteride affect the amount of dihydrotestosterone (DHT) in your blood. DHT is an important substance in the development of the male genitalia. This development starts in the womb and continues in men until the end of puberty. To prevent any risk (however small it may be!) of a genital abnormality in a male fetus, the prescription of finasteride and dutasteride is subject to strict rules.* The Intermedica clinic can prescribe finasteride or dutasteride to women under certain conditions. These conditions are: there is infertility (post-menopausal, sterilization) or finasteride or dutasteride is the only possible treatment in your situation (other treatments have proven to be ineffective or insufficiently effective) and you have been fully informed about the advantages and disadvantages of finasteride/dutasteride and you sign a statement about this (“informed consent”) and consultation has taken place with the pharmacy that supplies the medicine. It is solely the dermatologist who assesses and decides on each patient and circumstance. By the dermatologists of the Intermedica Clinic in 2013 in collaboration with internationally renowned trichologists conducted a retrospective study on the effectiveness of finasteride and dutasteride when used by women with androgenetic alopecia. You can read the results of this research here or download it in PDF format below. PDF scientific publication: “The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia”. Ids H. Boersma, Arnold P. Oranje, Ramon Grimalt, Matilde Iorizzo, Bianca M. Piraccini, Emiel H. Verdonschot *The Lareb side effects center received ten reports of possible side effects of finasteride/dutasteride in women in the period between 2005 and 2014. Two of these reports concerned the use of finasteride during pregnancy. On this basis, pharmacies are advised not to supply finasteride and dutasteride to fertile women. You can find Lareb's full message here.

Haaruitval bij vrouwen door ‘stress’
Telogeen effluvium

Jonge vrouw met dun haar stress telogeen effluvium.

Deze vorm van haaruitval bij vrouwen kan worden veroorzaakt door verschillende fysieke of psychische stressfactoren, zoals hoge koorts, infecties, bloedarmoede, operaties, ongevallen, emotionele problemen, streng diëten of alcoholmisbruik.

Na een bevalling ervaren veel vrouwen een fase van telogeen effluvium. Hierbij stopt de haarwortel met groeien en trekt het zich versneld terug in de rustfase van de haargroeicyclus, wat resulteert in verhoogd haarverlies bij het borstelen of door de handen door het haar halen. Gelukkig groeien de haren meestal na ongeveer zes maanden weer terug.

In sommige gevallen kan er sprake zijn van een chronisch telogeen effluvium, waarbij overmatige haaruitval bij vrouwen aanhoudt gedurende vele maanden tot zelfs jaren. Als je meer dan de gemiddelde 100 haren per dag verliest, kan dit duiden op telogeen effluvium en is het belangrijk om dit te laten onderzoeken.

  • What causes androgenetic alopecia?
    Each hair follicle can produce a hair approximately 20 times per lifetime, after which it dies. Because each hair remains in the hair follicle for three to five years, a person would only experience baldness after 60 to 90 years. Baldness at a young age with a hereditary cause is caused by the degree of sensitivity of certain hair follicles to the hormone dihydrotestosterone (DHT). This DHT is formed from the hormone testosterone under the influence of an enzyme (5-alpha-reductase, types I and II). The DHT binds to the androgen receptor (a 'biological magnet') of the hair follicle, which therefore has less blood flow. The growth phase of the hair is therefore shortened from three to five years to just a few months. The affected hairs become finer and shorter with each hair cycle and the hair follicle eventually dies at an accelerated rate. If this process occurs in many hair follicles, the hair becomes thinner. The number of androgen receptors a person has is genetically determined and that explains why some people go bald and others do not.
  • What treatment options are there for androgenetic alopecia?
    There are quite a few products and treatments that claim to have an effect on stopping hair loss due to androgenetic alopecia (hereditary baldness). Every two months a new shampoo, lotion or nutritional supplement comes onto the market with claimed effectiveness. Unfortunately, these claims are usually empty promises and the effect cannot be scientifically proven. However, there are also plenty of options whose effectiveness has been proven in scientific studies. Below is an overview of the treatment options used at Intermedica. The effectiveness of the products can be expressed as a percentage of full effectiveness, where hair loss is completely normalized. The effectiveness of the products for which scientific evidence is available is as follows (estimates): Minoxidil lotion: 25% Diane pill, Yasmin pill or Yaz pill: 25% Trix Basic Alpha + Trix Basic Beta: 25% Aminexil: 20% Androcur: 20% Other nutritional supplements: 0-10% Shampoos with Aminexil: 5% Other shampoos and lotions: 0-2% The effectiveness of the various products should not be added together. However, the effectiveness of one product can be improved slightly if another product is used. In addition, treatments are offered for which there is also only weak evidence that they inhibit the process of hair loss due to androgenetic alopecia. Examples of such treatments are light and laser treatments and the injection of vitamins and minerals into the scalp (PRP, mesotherapy). These are not carried out at Intermedica.
  • What about finasteride and dutasteride for women?
    The drugs finasteride and dutasteride have been prescribed for a long time and with good clinical results to women with hair loss due to androgenetic alopecia by the dermatologists of the Intermedica Clinic. These medicines are prescribed off-label. Off-label use of medicines means that they are prescribed for a purpose or in a different way than that for which they were approved. This is done based on a doctor's professional assessment. This is legally permitted. Finasteride and dutasteride were originally approved and prescribed for the treatment of prostate problems, but in low doses they also appear to be effective in preventing hair loss due to androgenetic alopecia, a so-called positive side effect. Finasteride and dutasteride affect the amount of dihydrotestosterone (DHT) in your blood. DHT is an important substance in the development of the male genitalia. This development starts in the womb and continues in men until the end of puberty. To prevent any risk (however small it may be!) of a genital abnormality in a male fetus, the prescription of finasteride and dutasteride is subject to strict rules.* The Intermedica clinic can prescribe finasteride or dutasteride to women under certain conditions. These conditions are: there is infertility (post-menopausal, sterilization) or finasteride or dutasteride is the only possible treatment in your situation (other treatments have proven to be ineffective or insufficiently effective) and you have been fully informed about the advantages and disadvantages of finasteride/dutasteride and you sign a statement about this (“informed consent”) and consultation has taken place with the pharmacy that supplies the medicine. It is solely the dermatologist who assesses and decides on each patient and circumstance. By the dermatologists of the Intermedica Clinic in 2013 in collaboration with internationally renowned trichologists conducted a retrospective study on the effectiveness of finasteride and dutasteride when used by women with androgenetic alopecia. You can read the results of this research here or download it in PDF format below. PDF scientific publication: “The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia”. Ids H. Boersma, Arnold P. Oranje, Ramon Grimalt, Matilde Iorizzo, Bianca M. Piraccini, Emiel H. Verdonschot *The Lareb side effects center received ten reports of possible side effects of finasteride/dutasteride in women in the period between 2005 and 2014. Two of these reports concerned the use of finasteride during pregnancy. On this basis, pharmacies are advised not to supply finasteride and dutasteride to fertile women. You can find Lareb's full message here.

Pleksgewijze kaalheid
Alopecia areata

Vrouw met alopecia areata

Bij pleksgewijze kaalheid, in de geneeskunde bekend als "alopecia areata" , kan haarverlies optreden in de vorm van ronde of ovale plekken zonder littekenvorming. Alopecia areata is een auto-immuunziekte: deze vorm van kaalheid wordt veroorzaakt door een storing in het afweersysteem. Hoewel er geen lichamelijke klachten zijn, kan het ziektebeeld wel zorgen voor bezorgdheid en angst bij de patiënt en hun familie.

De grootte van de ronde plekken kan variëren, zowel groter worden als kleiner. De kale plekken kunnen geheel of gedeeltelijk weer begroeid raken met haren. Na het verdwijnen van de kale plekken kunnen ze gedurende een lange periode wegblijven, maar ze kunnen ook na enkele maanden weer terugkeren. Het verloop van pleksgewijze kaalheid is dus onvoorspelbaar en kan variëren van persoon tot persoon. Alopecia areata komt voor bij vrouwen en mannen en in alle bevolkingsgroepen. Ongeveer 1 tot 2% van alle mensen krijgt ooit in het leven te maken met haaruitval door alopecia areata.

  • What causes androgenetic alopecia?
    Each hair follicle can produce a hair approximately 20 times per lifetime, after which it dies. Because each hair remains in the hair follicle for three to five years, a person would only experience baldness after 60 to 90 years. Baldness at a young age with a hereditary cause is caused by the degree of sensitivity of certain hair follicles to the hormone dihydrotestosterone (DHT). This DHT is formed from the hormone testosterone under the influence of an enzyme (5-alpha-reductase, types I and II). The DHT binds to the androgen receptor (a 'biological magnet') of the hair follicle, which therefore has less blood flow. The growth phase of the hair is therefore shortened from three to five years to just a few months. The affected hairs become finer and shorter with each hair cycle and the hair follicle eventually dies at an accelerated rate. If this process occurs in many hair follicles, the hair becomes thinner. The number of androgen receptors a person has is genetically determined and that explains why some people go bald and others do not.
  • What treatment options are there for androgenetic alopecia?
    There are quite a few products and treatments that claim to have an effect on stopping hair loss due to androgenetic alopecia (hereditary baldness). Every two months a new shampoo, lotion or nutritional supplement comes onto the market with claimed effectiveness. Unfortunately, these claims are usually empty promises and the effect cannot be scientifically proven. However, there are also plenty of options whose effectiveness has been proven in scientific studies. Below is an overview of the treatment options used at Intermedica. The effectiveness of the products can be expressed as a percentage of full effectiveness, where hair loss is completely normalized. The effectiveness of the products for which scientific evidence is available is as follows (estimates): Minoxidil lotion: 25% Diane pill, Yasmin pill or Yaz pill: 25% Trix Basic Alpha + Trix Basic Beta: 25% Aminexil: 20% Androcur: 20% Other nutritional supplements: 0-10% Shampoos with Aminexil: 5% Other shampoos and lotions: 0-2% The effectiveness of the various products should not be added together. However, the effectiveness of one product can be improved slightly if another product is used. In addition, treatments are offered for which there is also only weak evidence that they inhibit the process of hair loss due to androgenetic alopecia. Examples of such treatments are light and laser treatments and the injection of vitamins and minerals into the scalp (PRP, mesotherapy). These are not carried out at Intermedica.
  • What about finasteride and dutasteride for women?
    The drugs finasteride and dutasteride have been prescribed for a long time and with good clinical results to women with hair loss due to androgenetic alopecia by the dermatologists of the Intermedica Clinic. These medicines are prescribed off-label. Off-label use of medicines means that they are prescribed for a purpose or in a different way than that for which they were approved. This is done based on a doctor's professional assessment. This is legally permitted. Finasteride and dutasteride were originally approved and prescribed for the treatment of prostate problems, but in low doses they also appear to be effective in preventing hair loss due to androgenetic alopecia, a so-called positive side effect. Finasteride and dutasteride affect the amount of dihydrotestosterone (DHT) in your blood. DHT is an important substance in the development of the male genitalia. This development starts in the womb and continues in men until the end of puberty. To prevent any risk (however small it may be!) of a genital abnormality in a male fetus, the prescription of finasteride and dutasteride is subject to strict rules.* The Intermedica clinic can prescribe finasteride or dutasteride to women under certain conditions. These conditions are: there is infertility (post-menopausal, sterilization) or finasteride or dutasteride is the only possible treatment in your situation (other treatments have proven to be ineffective or insufficiently effective) and you have been fully informed about the advantages and disadvantages of finasteride/dutasteride and you sign a statement about this (“informed consent”) and consultation has taken place with the pharmacy that supplies the medicine. It is solely the dermatologist who assesses and decides on each patient and circumstance. By the dermatologists of the Intermedica Clinic in 2013 in collaboration with internationally renowned trichologists conducted a retrospective study on the effectiveness of finasteride and dutasteride when used by women with androgenetic alopecia. You can read the results of this research here or download it in PDF format below. PDF scientific publication: “The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia”. Ids H. Boersma, Arnold P. Oranje, Ramon Grimalt, Matilde Iorizzo, Bianca M. Piraccini, Emiel H. Verdonschot *The Lareb side effects center received ten reports of possible side effects of finasteride/dutasteride in women in the period between 2005 and 2014. Two of these reports concerned the use of finasteride during pregnancy. On this basis, pharmacies are advised not to supply finasteride and dutasteride to fertile women. You can find Lareb's full message here.

Kaalheid in de voorste haarlijn
Frontale fibroserende alopecie

Vrouw met kaalheid in de voorste haarlijn

Frontale fibroserende alopecie, ook wel bekend als FFA, is een chronische inflammatoire vorm van haarverlies die vooral vrouwen treft na de menopauze. Het kan zich kenmerken door het geleidelijk terugtrekken van de haargrens aan de voorzijde en zijkanten van de hoofdhuid, vaak gepaard gaande met roodheid, jeuk en een branderig gevoel. Hoewel de exacte oorzaak van FFA onbekend is, wordt het verondersteld een auto-immuunziekte te zijn, waarbij het immuunsysteem de haarfollikels aanvalt en littekenvorming veroorzaakt.
 

Diagnose van FFA wordt gesteld op basis van klinisch onderzoek en soms een huidbiopsie. Er zijn voor FFA behandelingsopties beschikbaar om de progressie van de aandoening te vertragen.


​De aandoening kan hardnekkig zijn, dooft uiteindelijk uit, maar zal soms onomkeerbaar haarverlies veroorzaken.

  • What causes androgenetic alopecia?
    Each hair follicle can produce a hair approximately 20 times per lifetime, after which it dies. Because each hair remains in the hair follicle for three to five years, a person would only experience baldness after 60 to 90 years. Baldness at a young age with a hereditary cause is caused by the degree of sensitivity of certain hair follicles to the hormone dihydrotestosterone (DHT). This DHT is formed from the hormone testosterone under the influence of an enzyme (5-alpha-reductase, types I and II). The DHT binds to the androgen receptor (a 'biological magnet') of the hair follicle, which therefore has less blood flow. The growth phase of the hair is therefore shortened from three to five years to just a few months. The affected hairs become finer and shorter with each hair cycle and the hair follicle eventually dies at an accelerated rate. If this process occurs in many hair follicles, the hair becomes thinner. The number of androgen receptors a person has is genetically determined and that explains why some people go bald and others do not.
  • What treatment options are there for androgenetic alopecia?
    There are quite a few products and treatments that claim to have an effect on stopping hair loss due to androgenetic alopecia (hereditary baldness). Every two months a new shampoo, lotion or nutritional supplement comes onto the market with claimed effectiveness. Unfortunately, these claims are usually empty promises and the effect cannot be scientifically proven. However, there are also plenty of options whose effectiveness has been proven in scientific studies. Below is an overview of the treatment options used at Intermedica. The effectiveness of the products can be expressed as a percentage of full effectiveness, where hair loss is completely normalized. The effectiveness of the products for which scientific evidence is available is as follows (estimates): Minoxidil lotion: 25% Diane pill, Yasmin pill or Yaz pill: 25% Trix Basic Alpha + Trix Basic Beta: 25% Aminexil: 20% Androcur: 20% Other nutritional supplements: 0-10% Shampoos with Aminexil: 5% Other shampoos and lotions: 0-2% The effectiveness of the various products should not be added together. However, the effectiveness of one product can be improved slightly if another product is used. In addition, treatments are offered for which there is also only weak evidence that they inhibit the process of hair loss due to androgenetic alopecia. Examples of such treatments are light and laser treatments and the injection of vitamins and minerals into the scalp (PRP, mesotherapy). These are not carried out at Intermedica.
  • What about finasteride and dutasteride for women?
    The drugs finasteride and dutasteride have been prescribed for a long time and with good clinical results to women with hair loss due to androgenetic alopecia by the dermatologists of the Intermedica Clinic. These medicines are prescribed off-label. Off-label use of medicines means that they are prescribed for a purpose or in a different way than that for which they were approved. This is done based on a doctor's professional assessment. This is legally permitted. Finasteride and dutasteride were originally approved and prescribed for the treatment of prostate problems, but in low doses they also appear to be effective in preventing hair loss due to androgenetic alopecia, a so-called positive side effect. Finasteride and dutasteride affect the amount of dihydrotestosterone (DHT) in your blood. DHT is an important substance in the development of the male genitalia. This development starts in the womb and continues in men until the end of puberty. To prevent any risk (however small it may be!) of a genital abnormality in a male fetus, the prescription of finasteride and dutasteride is subject to strict rules.* The Intermedica clinic can prescribe finasteride or dutasteride to women under certain conditions. These conditions are: there is infertility (post-menopausal, sterilization) or finasteride or dutasteride is the only possible treatment in your situation (other treatments have proven to be ineffective or insufficiently effective) and you have been fully informed about the advantages and disadvantages of finasteride/dutasteride and you sign a statement about this (“informed consent”) and consultation has taken place with the pharmacy that supplies the medicine. It is solely the dermatologist who assesses and decides on each patient and circumstance. By the dermatologists of the Intermedica Clinic in 2013 in collaboration with internationally renowned trichologists conducted a retrospective study on the effectiveness of finasteride and dutasteride when used by women with androgenetic alopecia. You can read the results of this research here or download it in PDF format below. PDF scientific publication: “The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia”. Ids H. Boersma, Arnold P. Oranje, Ramon Grimalt, Matilde Iorizzo, Bianca M. Piraccini, Emiel H. Verdonschot *The Lareb side effects center received ten reports of possible side effects of finasteride/dutasteride in women in the period between 2005 and 2014. Two of these reports concerned the use of finasteride during pregnancy. On this basis, pharmacies are advised not to supply finasteride and dutasteride to fertile women. You can find Lareb's full message here.

Maak jij je zorgen over je haar?
Wij kunnen helpen!

Merk je dat je haar steeds dunner wordt? Verlies je meer haren dan normaal? Is je haargrens veranderd ten opzichte van vroeger? Maak je je zorgen over de afname van kwaliteit van je haar en wil je weten wat je kunt doen?
Onze dermatologen zijn experts op het gebied van haarproblemen.

Tijdens een consult wordt er een grondige diagnose gesteld en worden uitgebreid de behandelmogelijkheden met je besproken, samen met wat je daarvan kunt verwachten. We begrijpen dat haarverlies een emotionele impact kan hebben en ons team van professionals staat klaar om je te ondersteunen en de best mogelijke oplossingen te bieden.

Over Intermedica Kliniek

De Intermedica Kliniek is het toonaangevende expertisecentrum voor haarproblemen in Nederland. Huisartsen, dermatologen en (universitaire) ziekenhuizen verwijzen patiënten met haarziekten, overmatig haarverlies of dunner wordend haar naar de Intermedica Kliniek.

bottom of page